Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of January 31, 2026

Rhea-AI Summary

DBVT (NYSE Euronext Paris) disclosed its total shares and voting rights as of January 31, 2026 under Article 223-16 of the AMF General Regulations.

The company reported 274,852,082 total shares and a gross total of 274,852,082 voting rights, with a net total of 274,792,237 voting rights (excluding shares without voting rights).

News Market Reaction – DBVT

-0.93% 1.5x vol

7 alerts

-0.93% News Effect

-18.7% Trough in 30 hr 5 min

-$11M Valuation Impact

$1.19B Market Cap

1.5x Rel. Volume

On the day this news was published, DBVT declined 0.93%, reflecting a mild negative market reaction. Argus tracked a trough of -18.7% from its starting point during tracking. Our momentum scanner triggered 7 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $11M from the company's valuation, bringing the market cap to $1.19B at that time. Trading volume was above average at 1.5x the daily average, suggesting increased trading activity.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Total shares: 274,852,082 Total gross voting rights: 274,852,082 Total net voting rights: 274,792,237 +1 more

4 metrics

Total shares 274,852,082 Total number of shares as of Jan 31, 2026

Total gross voting rights 274,852,082 Total gross voting rights as of Jan 31, 2026

Total net voting rights 274,792,237 Total net voting rights as of Jan 31, 2026

ISIN code FR 0010417345 Identification for DBV Technologies shares on Euronext Paris

Market Reality Check

Price: $19.63 Vol: Volume 425,025 vs 20-day ...

normal vol

$19.63 Last Close

Volume Volume 425,025 vs 20-day average 492,177 (relative volume 0.86x). normal

Technical Price 21.46 is trading above the 200-day MA of 12.73, indicating a pre-news uptrend.

Peers on Argus

DBVT was up 4.04% while close peers CADL, OMER, ANNX, CAPR and NGNE were down be...

DBVT was up 4.04% while close peers CADL, OMER, ANNX, CAPR and NGNE were down between -4.60% and -6.04%, indicating stock-specific dynamics rather than a sector move.

Historical Context

5 past events · Latest: Jan 16 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Jan 16	Warrant exercise proceeds	Positive	+0.5%	€166.7M gross proceeds from full exercise of ABSA and BS warrants.
Jan 12	Voting rights update	Neutral	-5.0%	Updated total shares and voting rights as of Dec 31, 2025.
Jan 07	Liquidity contract report	Neutral	+8.2%	Half-year report on liquidity contract share and cash positions.
Jan 05	Voting rights update	Neutral	-10.8%	Initial disclosure of Dec 31, 2025 share and voting-right totals.
Dec 16	Phase 3 trial results	Positive	-1.7%	Positive Phase 3 VITESSE topline data for VIASKIN Peanut in children 4–7.

Pattern Detected

Operational and clinical news have often seen mixed or negative next-day reactions, while routine voting-rights disclosures have sometimes coincided with notable declines.

Recent Company History

Over the last few months, DBV Technologies has reported several capital markets and operational milestones. On Dec 16, 2025, positive Phase 3 VITESSE topline data for VIASKIN Peanut were released, followed by an 8-K. Subsequent disclosures covered share and voting-right updates on Dec 31, 2025 and Jan 12, 2026, and a liquidity contract report on Jan 7, 2026. On Jan 16, 2026, the company announced €166.7M in gross proceeds from warrant exercises. Today’s voting-rights update continues this sequence of capital structure transparency.

Market Pulse Summary

This announcement formalizes DBV Technologies’ share capital as of January 31, 2026, reporting 274,8...

Analysis

This announcement formalizes DBV Technologies’ share capital as of January 31, 2026, reporting 274,852,082 total shares, with 274,852,082 gross and 274,792,237 net voting rights under Article 223-16 of the AMF rules. It follows prior disclosures on warrant exercises and share issuances, giving an updated reference point for ownership percentages and regulatory filings. Investors tracking historical ownership changes and governance metrics may monitor how future filings reference these new totals.

Key Terms

voting rights, isin, autorité des marchés financiers, article 223-16

4 terms

voting rights regulatory

"Total Number of Voting Rights and Total Number of Shares of the Company"

Voting rights are the ability of shareholders to have a say in important company decisions, like choosing leaders or approving big changes. They matter because they give owners a voice in how the company is run, similar to how voters influence elections, ensuring the company acts in shareholders’ interests.

isin regulatory

"Market : NYSE Euronext Paris ISIN Code: FR 0010417345"

A 12-character International Securities Identification Number (ISIN) is a unique code that acts like a passport for a specific stock, bond or other tradable security so it can be identified worldwide. Investors and systems use it to ensure they are buying, selling and tracking the exact same instrument across exchanges and data feeds, which prevents costly mix-ups and makes portfolio reporting, settlement and regulatory checks simpler and more reliable.

autorité des marchés financiers regulatory

"Article 223-16 of the General Regulations of the Autorité des Marchés Financiers"

Autorité des marchés financiers is the French-language name for an independent government agency that supervises and enforces rules for securities markets, financial firms, and investor protection. It matters to investors because it requires companies to publish accurate information, polices fraud and insider trading, and can suspend trading or impose penalties—acting like a referee and safety inspector to help markets stay fair and reliable and to give investors confidence and recourse.

article 223-16 regulatory

"as of January 31, 2026 (Article 223-16 of the General Regulations"

Article 223-16 is a rule that requires certain financial firms, like banks and investment companies, to report their large or suspicious transactions to authorities. This helps prevent illegal activities such as money laundering or fraud, making the financial system safer and more transparent.

AI-generated analysis. Not financial advice.

Information Regarding the Total Number of Voting Rights and 
Total Number of Shares of the Company as of January 31, 2026

(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)

Market : NYSE Euronext Paris
ISIN Code: FR 0010417345

Date	Total number of shares	Total number of voting rights
01/31/2026	274,852,082	Total gross of voting rights: 274,852,082
		Total net* of voting rights: 274,792,237

* Net total = total number of voting rights attached to shares – shares without voting rights

Attachment

• PDF Version

FAQ

How many total shares did DBVT report as of January 31, 2026?

DBVT reported 274,852,082 total shares as of January 31, 2026. According to DBVT, this figure is the company’s issued share count used to calculate voting rights under AMF rules for that date.

What is the difference between gross and net voting rights for DBVT on 01/31/2026?

The gross voting rights equal 274,852,082, while net voting rights equal 274,792,237. According to DBVT, the net total excludes shares without voting rights, producing the slight reduction in count.

Why does DBVT publish voting rights information on January 31, 2026?

DBVT publishes voting rights to comply with Article 223-16 of the AMF General Regulations. According to DBVT, this disclosure notifies the market of the precise gross and net voting rights and share count at that date.

Where can investors find DBVT’s official voting rights and share count for January 31, 2026?

Investors can access the official figures via DBVT’s regulatory disclosures and the attached PDF version of the notice. According to DBVT, the published table shows both total shares and gross/net voting rights.